Home
Search
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

General Events Sign Up Page

Desperate to stop a drug-resistant infection
Good Day BIO Newsletter  •  November 14, 2023
After contracting a drug-resistant infection that wouldn’t go away, a patient developed his own wound dressing—but why would he need to do this? The I am BIO Podcast explores Bradley Burnam’s story, and the state of the antimicrobials market. Plus, BIO launches a powerful new resource for early-stage biotech companies. (576 words, 2 minutes, 52 seconds)
Read More

Climate Policy Innovation Series: Food and Agriculture Systems
Webinars  •  November 14, 2023
View this conversation highlighting how BIO member companies are strengthening food security and addressing climate change through biotechnology innovations in crop protection and efficient food production. Learn how regulation and policy can support agricultural innovation to protect our environment and our food supply.
Read More
Food and Farm Innovation

“On My Own”—Desperate to Stop a Resistant Bacterial Infection
I am BIO Podcast  •  November 14, 2023
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to "mad scientist" to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace.
Read More
“On My Own”—Desperate to Stop a Resistant Bacterial Infection

World's first chikungunya vaccine
Good Day BIO Newsletter  •  November 13, 2023
While a potential government shutdown looms, we’re looking at exciting biotech innovations—from the world’s first vaccine for chikungunya virus, to promising treatments for a range of cardiovascular diseases. (465 words, 2 minutes, 19 seconds)
Read More

BIO and BIO member Letter to Congressional Leadership on the Medical Countermeasures (MCM) Priority Review Voucher (PRV) program
Letters, Testimony & Comments  •  November 10, 2023
BIO and BIO members are urging lawmakers to enact a short-term extension of the MCM-PRV program while Congress is waiting to address a full reauthorization with PAHPA.
Read More

Opposing CMS rule, advancing SAF
Good Day BIO Newsletter  •  November 10, 2023
Members of Congress joined the chorus against CMS’ proposed rule on the Medicaid Drug Rebate Program, and several U.S. Representatives introduced a bill to advance SAF. Ahead of Veterans Day, we look at how biotech—including BIO’s vice chair—is recognizing and supporting veterans. (684 words, 3 minutes, 25 seconds)  
Read More

How you can take action on PBMs
Good Day BIO Newsletter  •  November 9, 2023
The Senate Finance Committee advanced critically important PBM transparency legislation—here’s what happened and how you can take action. Plus, BIO joined 45+ organizations in condemning the Biden administration’s recent decision on international data flows. (703 words, 3 minutes, 30 seconds)
Read More

BIO Partnering at JPM Week Overview
Webinars  •  November 9, 2023
Looking for an efficient and effective way to source new partnerships and manage your meetings for JPM Week? This webinar explains how BIO One-on-One Partnering™ can help. Learn about BIO’s onsite meeting space in San Francisco, tips and tricks for using the system, and how to schedule your meetings with different location options. Also, get a look at how you can stay in-the-know about networking and other opportunities during JPM Week. For more information about BIO Partnering at JPM Week, please visit: https://www.bio.org/events/bio-partnering-jpm This webinar covers the following:  - Preview of BIO’s onsite meeting space in San Francisco  -Partnering best practices & how to schedule your meetings - Live demo of the partnering system & advanced features - Intro to BIO and Novateur Ventures’ JPM Week Events Guide mobile app - Q&A with the host Quick Links: Copy of today’s slides: PowerPoint Presentation (bio.org) Registration rates & where to register: https://bpjw.bio.org/registration 2024 Participating companies: https://bpjw.bio.org/participating-companies 2024 Participating investors: https://bpjw.bio.org/bio-one-one-partnering/participating-investors Guide to JPM’24 mobile app for iPhone: https://apps.apple.com/mu/app/guide-to-jpm23/id1494244381 Guide to JPM’24 mobile app for Android: https://play.google.com/store/apps/details?id=org.novateur.ConferenceGuide Submit your JPM Week event for our mobile app & Dec 12 webinar event list: https://forms.office.com/pages/responsepage.aspx?id=FmEqTcAdB0iptW1DmWAlb-7aiIadk1dGqhpdctNwLzRUM0pDVkYzQVlDTFJTQUJJMVpWTUVPSFUzSi4u Register for the Dec 12th JPM Networking Webinar: https://www.bio.org/webinars/raising-capital/bios-jpm-week-events-networking-preview  
Read More
partnering at jpm week

BIO Regulatory Affairs Steering Committee (RASC) Meeting
November 8, 2023
The BIO Regulatory Affairs Steering Committee (RASC) acts as a steering committee for all staff-level science & regulatory committees and working groups. The RASC takes the lead or makes assignments to committees and working groups on implementation of user fee agreements, including continuous engagement activities with FDA. The RASC develops and implements strategic BIO responses to scientific and regulatory issues that affect the ability of BIO's human healthcare focused companies to research and develop new therapeutics, and to bring these products to market. The RASC responds to proposed regulations and draft guidance documents as necessary and holds liaison meetings with FDA to identify and discuss regulatory best practices. For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).
Read More